K252818 is an FDA 510(k) clearance for the Dexcom Smart Basal. This device is classified as a Continuous Glucose Monitor Informed Insulin Dose Calculator (Class II - Special Controls, product code QRX).
Submitted by Dexcom, Inc. (San Diego, US). The FDA issued a Cleared decision on November 18, 2025, 75 days after receiving the submission on September 4, 2025.
This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1358. A Continuous Glucose Monitor (cgm)-informed Insulin Dose Calculator Is A Software Device That Calculates Suggested Insulin Doses Based On Cgm Values And/or Other Relevant Information..
| 510(k) Number | K252818 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | September 04, 2025 |
| Decision Date | November 18, 2025 |
| Days to Decision | 75 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | QRX — Continuous Glucose Monitor Informed Insulin Dose Calculator |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 862.1358 |
| Definition | A Continuous Glucose Monitor (cgm)-informed Insulin Dose Calculator Is A Software Device That Calculates Suggested Insulin Doses Based On Cgm Values And/or Other Relevant Information. |